"Extracts from Rabbit Skin Inflamed by Vaccinia Virus for Injection" (lizaishi) is a therapeutic biological product containing a variety of globally patented biological small molecular peptides. It can relieve a variety of symptoms of symptomatic neuralgia or neuropathic pain. Due to its analgesic effect and unique curative effect, it has been widely recognized and applied in China.
On June 15, 2017, the product was awarded the "national drug standard issuance document" by the State Food and drug administration, and the quality standard number is: WS4-(S-001)-2017Z。
After more than 20 years of research and development and clinical verification, it was found that this product is a drug that can regenerate neurons and reduce the injury of the inflammatory body, and has significant curative effect on various central and peripheral nerve injury diseases.
R & D listing
The drug registration standard (ws4- (s-001) -2017z) issued by CFDA was obtained on June 15, 2017, and the generic name of the drug was "Extracts from Rabbit Skin Inflamed by Vaccinia Virus for Injection". Subsequently, with the approval of the drug registration department of the State Food and drug administration, the trade name was "LEPALVIR" on January 24, 2018.
R & D listing
Clinically significant efficacy
"Extracts from Rabbit Skin Inflamed by Vaccinia Virus for Injection" is a therapeutic biological product produced by Weishi Pharmaceutical (Rugao) Co., Ltd. Clinically, it is mainly used for the treatment of "neck, shoulder and wrist syndrome; relief of pain, cold sensation, numbness and other symptoms of patients with low back pain; symptomatic neuralgia".
Clinically significant efficacy
extraction process
Lizaishi is a colorless or yellowish liquid obtained by inoculating vaccinia virus into healthy rabbits and roughing and refining the inflamed rabbit skin. The drug test report showed that lizaimedia contained a variety of amino acids and nucleotides. The molecular weight of the components of lizaishi is less than 2000 daltons, which can pass through the blood-brain barrier.
extraction process
Repair residual neurological symptoms such as pain, numbness and cold sensation after spinal surgery; Treat pain, numbness, cold sensation, etc. of non-surgical patients with cervical and lumbar diseases Review literature >>
All kinds of neuralgia (sciatica, postherpetic neuralgia, cervical spondylotic radiculopathy, occipital neuralgia, etc.), as well as neurosis caused by multiple sclerosis Review literature >>
All kinds of neuropathic pain anesthesiology assisted analgesia, reduce the dosage of narcotic analgesics Review literature >>
Pain and numbness caused by diabetic peripheral neuropathy Review literature >>
Herpes zoster neuralgia and postherpetic neuralgia Review literature >>
Neurotoxic side effects caused by tumor radiotherapy and chemotherapy Review literature >>
苏ICP备 19025xxx号-1 苏公网安备3101070200xxxx号
Copyright © 2024 Vanworld Pharmaceutical (Rugao) Company Limited All Rights Reserved
Scan code follow us